BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schwenk HT, Bio LL, Kruger JF, Banaei N. Clinical Impact of Clostridium difficile PCR Cycle Threshold-Predicted Toxin Reporting in Pediatric Patients. J Pediatric Infect Dis Soc 2020;9:44-50. [PMID: 30476169 DOI: 10.1093/jpids/piy117] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Emberger J, Hitchcock MM, Markley JD. Diagnostic Stewardship Approaches to Clostridioides difficile Infection in the Era of Two-Step Testing: a Shifting Landscape. Curr Treat Options Infect Dis 2020;12:258-74. [DOI: 10.1007/s40506-020-00223-8] [Reference Citation Analysis]
2 Bouza E, Aguado JM, Alcalá L, Almirante B, Alonso-Fernández P, Borges M, Cobo J, Guardiola J, Horcajada JP, Maseda E, Mensa J, Merchante N, Muñoz P, Pérez Sáenz JL, Pujol M, Reigadas E, Salavert M, Barberán J. Recommendations for the diagnosis and treatment of Clostridioides difficile infection: An official clinical practice guideline of the Spanish Society of Chemotherapy (SEQ), Spanish Society of Internal Medicine (SEMI) and the working group of Postoperative Infection of the Spanish Society of Anesthesia and Reanimation (SEDAR). Rev Esp Quimioter 2020;33:151-75. [PMID: 32080996 DOI: 10.37201/req/2065.2020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
3 Hansen G, Young S, Wu AHB, Herding E, Nordberg V, Mills R, Griego-Fullbright C, Wagner A, Ong CM, Lewis S, Yoon J, Estis J, Sandlund J, Friedland E, Carroll KC. Ultrasensitive Detection of Clostridioides difficile Toxins in Stool by Use of Single-Molecule Counting Technology: Comparison with Detection of Free Toxin by Cell Culture Cytotoxicity Neutralization Assay. J Clin Microbiol 2019;57:e00719-19. [PMID: 31434724 DOI: 10.1128/JCM.00719-19] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Han SH, Yi J, Kim JH, Lee S, Moon HW. Composition of gut microbiota in patients with toxigenic Clostridioides (Clostridium) difficile: Comparison between subgroups according to clinical criteria and toxin gene load. PLoS One 2019;14:e0212626. [PMID: 30785932 DOI: 10.1371/journal.pone.0212626] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
5 Hitchcock MM, Holubar M, Hogan CA, Tompkins LS, Banaei N. Dual Reporting of Clostridioides difficile PCR and Predicted Toxin Result Based on PCR Cycle Threshold Reduces Treatment of Toxin-Negative Patients without Increases in Adverse Outcomes. J Clin Microbiol 2019;57:e01288-19. [PMID: 31511334 DOI: 10.1128/JCM.01288-19] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Miller R, Morillas JA, Brizendine KD, Fraser TG. Predictors of Clostridioides difficile Infection-Related Complications and Treatment Patterns among Nucleic Acid Amplification Test-Positive/Toxin Enzyme Immunoassay-Negative Patients. J Clin Microbiol 2020;58:e01764-19. [PMID: 31896665 DOI: 10.1128/JCM.01764-19] [Cited by in Crossref: 6] [Article Influence: 3.0] [Reference Citation Analysis]